1. Laboratories Oversight Board 14th March 2019
Programme Performance Update – Reporting Period 23/01/19 to 07/03/19

2. Regular Update Items Key Highlights Programme Budget Programme Metrics
Key Risks & Issues
Stakeholder
Engagement
Key Milestones
Change Control
Requests
Project Updates

3. Blueprint Development Engagement & Communications
Key Highlights
IT Connectivity
NLIIP
Completion of final report for Proof of Concept with recommendations for preferred way forward for phase 1
Further demos of dashboard to West region and West Region Laboratories Board
Engagement with stakeholders on preferred way forward
Start up meeting complete at NHS Highland.
Induction meetings with Golden Jubilee Hospital and NHS Lanarkshire
User acceptance training progressing in Borders
NPEx roadshow event planning
Exploratory meeting for NPEx applicability to supporting TB testing
Notable Highlights
Blueprint Development
Engagement & Communications
Workshop delivered with North region and draft priorities
TB Diagnosis Options Business Case reviewed by Blueprint Subgroup for alignment with Blueprint
Standardisation group being established after agreement from LOB and regions
Labs website now live
Joint planning for engagement event in NHS Fife 22/03/19
Initial meeting with Access Collaborative
Results plus meeting

4. Key Programme Metrics @ 7th March 2019
Stakeholder Engagement
Programme Budget
Programme Resources
Overall Programme Status
Benefits Realisation
Programme Schedule
Programme Leadership

5. Programme Metrics Commentary
Explanatory Commentary
Stakeholder engagement (G)
Stakeholder engagement continuing through the regional groups, networks, IG leads and eHealth leads. Local stakeholder events taken place in North region and being planned in the East region.
Programme Budget (R)
Metric is currently red as per last report with current year end forecast position with an underspend of approximately £380k due to further delay in slower mobilisation than anticipated and additional delays in NPEx deployments. Conversations are ongoing regarding the ability to bid for the carry forward of underdspend monies into 19/20. The programme metric tolerance position of >5% places this metric at red.
Programme Resources (A)
Metric remains at amber as per previous report, core programme team currently have a vacancy for a Programme Director. The role is now being advertised with closing date of 22/03/19.
Benefits Realisation (G)
Committed business case benefits are to be realised from year 2 (19/20) onwards. Current activity focuses on the development of a benefits methodology and approach for presentation to the LOB in March.
Programme Schedule (A)
Programme plan remains at amber with pressure on timescales for NPEx deployments specifically obtaining information governance approval from NHS Ayrshire and Arran and a set up risk with NHS Forth Valley creating delays. Start dates are not yet confirmed for either of these Boards.
Programme Leadership (A)
Metric remains at amber due to Labs Programme Director vacancy however interim arrangements are working well with support from NSS Healthcare Science Director and Portfolio Manager.
Overall Programme (A)
Overall, subjective, metric stays at amber consistent with last performance report. This is due to delays in NPEx deployment, underspend on budget and pressures coming through on other key milestones. Positive progress made in final report for NLIIP proof of concept, organisational readiness for Boards deploying NPEx in tranche 3, stakeholder engagement, developing national roadmap and strengthening programme governance through standardisation group and DSM clinical leads group.

6. Change Control Requests & Decisions
7th March 2019
0 Changes
1 business case received from DSG

7. Stakeholder Engagement & Communications
F2F engagement
Social media on hold
Laboratory staff engagement sessions planned with East Region 22/03/19
Programme website has gone live
Newsletter circulated
Leaflet produced
Access Collaborative,

8. Risks, Issues & Dependencies
Summary
Risks
Issues
Red 4
Amber
Green 2 1
Issues
IG sign off on data sharing agreement for NHS Forth Valley
Configuration of VPN tunnel NHS Shetland
Conflict between the IP address ranges used at Forth Valley (192.xx.xx.xx) and those utilised by THIS
Current Forth Valley infrastructure cannot facilitate the required VPN connection for NPEx

11. Project Status Updates
IT Connectivity Delivery Project 1
National Laboratories Intelligence & Information Platform Delivery Project 2
Blueprint Development & Benefits Workstream 3

12. IT Connectivity Project
This Period
Last Period
Amber
Start up meeting with NHS Highland
Introductory meetings with NHS Lanarkshire, Golden Jubilee Hospital
IG sign off NHS Shetland
NHS Borders pipe clean testing
NPEx roadshow planning
Exploratory discussion with Xlabs re applicability of NPEx to TB testing requests
Delivered this period
IG sign off NHS Ayrshire and Arran, NHS Orkney
Rescheduling of NHS Forth Valley deployment
Technical connectivity issues with NHS Forth Valley
Challenges
Actions for next period
Complete expansion plan for all Boards
NHS Borders move to testing in live environment
IG sign off NHS Ayrshire and Arran and NHS Orkney and commence deployment
Solution for technical connectivity issue with NHS Forth Valley
Complete organisational readiness and deployment initiation with NHS Shetland

13. National Laboratories Intelligence & Information Platform Project
This Period
Last Period
Amber
Green
National Laboratories Intelligence & Information Platform Project
Delivered this period
Agreeing approach for phase 1 development
Challenges
Agree discipline priorities for phase 1 development of LOB
Produce plan for delivery of phase 1
Commence development activity for phase 1
Actions for next period
Profile NHS Borders data and add to dashboard
Final report produced
Focus group with West region
Engagement sessions with remaining Boards
Learning session with SNBTS and SCI store

14. Blueprint Development & Benefits Workstream
This Period
Last Period
Green
Amber
Blueprint Development & Benefits Workstream
Delivered this period
Communicating the Blueprint more widely with Laboratories stakeholders
Governance of operational improvements vs. service transformation
Challenges
Actions for next period
Further development of roadmap and action plans
Agreed date, structure for West region workshop
First meeting of DSM Clinical Leads Subgroup
First meeting of Standardisation Subgroup
North region workshop delivered with priority outputs
Draft national roadmap of priorities
ToR produced for standardisation Subgroup
ToR produced for DSM Clinical Leads Subgroup
Assessment of C-peptide testing and subsequent antibody and genetic testing Business Case against Blueprint alignment tool

15. Next LABORATORIES Oversight Board – 23 April
2019
Next LABORATORIES Oversight Board – 23 April